DEFA14A ·Filed Apr 23, 2026
Proxy solicitation materials
Actionable Insight • Neutral
Monitor for any subsequent filings related to the shareholder vote outcome or further board changes.
Final — all horizons settled through T+60d
DSGN ▼ -3.75% at T+60d
NEUTRAL call -3.75% · α vs SPY -8.83% · entry $12.53 → $12.06
T+1d
+2.23%
call +2.23% · α +2.07%
$12.81
settled 6mo ago
T+5d
+8.54%
call +8.54% · α +7.63%
$13.60
settled 6mo ago
T+20d
-12.13%
call -12.13% · α -16.16%
$11.01
settled 5mo ago
T+60d
-3.75%
call -3.75% · α -8.83%
$12.06
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Design Therapeutics is holding its annual shareholder meeting on June 9, 2026, to vote on electing one Class II director and ratifying the selection of Ernst & Young LLP as the independent auditor. This filing follows the recent appointment of David Shapiro to the board, indicating ongoing governance activity.
Key Financial Metrics
Vote
director election
Meeting
2026-06-09
Seats Contested
1
Key Facts
- Annual meeting scheduled for June 9, 2026.
- Two proposals: elect one Class II director and ratify Ernst & Young LLP as independent auditor.
- Board recently appointed David Shapiro, M.D., as a Class III director on March 31, 2026.
Financial Impact
No direct financial impact reported.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-173689 |
| Document: 0001193125-26-173689-index-headers.html | 0001193125-26-173689 |
| Document: 0001193125-26-173689-index.html | 0001193125-26-173689 |
| Document: 0001193125-26-173689.txt | 0001193125-26-173689 |
8 reports for DSGN
80% Hit rate @ T+20 Went positive at some point 4 of 5 best @ T+60▲ +37.01%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 3, 2026 12w ago | 8-K | $12.76 $15.09 | ▲ +18.26% | ▲ +17.02% | $10.34 (−18.97%) |
Aug 3, 2026 12w ago | Press Release | $12.76 $15.09 | ▲ +18.26% | ▲ +17.02% | $10.34 (−18.97%) |
May 18, 2026 23w ago | 8-K | $10.70 $10.72 | ▲ +0.19% | ▼ −1.39% | $10.34 (−3.36%) |
May 18, 2026 23w ago | Press Release | $10.70 $10.72 | ▲ +0.19% | ▼ −1.39% | $10.34 (−3.36%) |
May 17, 2026 23w ago | Press Release | $10.70 $10.72 | ▲ +0.19% | ▼ −1.39% | $10.34 (−3.36%) |
Apr 28, 2026 25w ago | Press Release | $15.79 $11.10 | ▼ −29.70% | ▼ −35.16% | $10.34 (−34.52%) |
Apr 23, 2026 26w ago | DEFA14A | $12.53 $11.01 | ▼ −12.13% | ▼ −16.16% | $10.34 (−17.48%) |
Apr 1, 2026 29w ago | 3 | $11.23 $13.60 | ▲ +21.10% | ▲ +11.23% | $10.34 (−7.93%) |
Showing 8 of 8
US Market Status
Market Closed — Opens Tue (15h 54m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers